| Product NDC: | 0004-0259 |
| Proprietary Name: | CellCept |
| Non Proprietary Name: | Mycophenolate Mofetil |
| Active Ingredient(s): | 250 mg/1 & nbsp; Mycophenolate Mofetil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0004-0259 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050722 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950503 |
| Package NDC: | 0004-0259-43 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-43) > 500 CAPSULE in 1 BOTTLE, PLASTIC |
| NDC Code | 0004-0259-43 |
| Proprietary Name | CellCept |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-43) > 500 CAPSULE in 1 BOTTLE, PLASTIC |
| Product NDC | 0004-0259 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mycophenolate Mofetil |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19950503 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | MYCOPHENOLATE MOFETIL |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |